<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>2018 (11) TMI 1124 - ITAT MUMBAI</title>
    <link>https://www.taxtmi.com/caselaws?id=370781</link>
    <description>The Tribunal allowed the appeal, directing deletion of disallowances made by the Assessing Officer and upheld by the CIT(A). The expenses were incurred for business promotion and not prohibited by statute. CBDT Circular No. 5 was deemed inapplicable for the relevant assessment year, and MCI guidelines did not apply to pharmaceutical companies. The decision was pronounced on 20/11/2018.</description>
    <language>en-us</language>
    <pubDate>Tue, 20 Nov 2018 00:00:00 +0530</pubDate>
    <lastBuildDate>Fri, 23 Nov 2018 09:38:12 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=543400" rel="self" type="application/rss+xml"/>
    <item>
      <title>2018 (11) TMI 1124 - ITAT MUMBAI</title>
      <link>https://www.taxtmi.com/caselaws?id=370781</link>
      <description>The Tribunal allowed the appeal, directing deletion of disallowances made by the Assessing Officer and upheld by the CIT(A). The expenses were incurred for business promotion and not prohibited by statute. CBDT Circular No. 5 was deemed inapplicable for the relevant assessment year, and MCI guidelines did not apply to pharmaceutical companies. The decision was pronounced on 20/11/2018.</description>
      <category>Case-Laws</category>
      <law>Income Tax</law>
      <pubDate>Tue, 20 Nov 2018 00:00:00 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/caselaws?id=370781</guid>
    </item>
  </channel>
</rss>